Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05362344Active Not Recruiting

Colorectal Cancer Screening in Cystic Fibrosis

Role: lead

NCT06654752Not ApplicableRecruiting

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Role: lead

NCT00005133Active Not Recruiting

Cardiovascular Health Study (CHS)

Role: collaborator

NCT04608019Not ApplicableCompleted

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study

Role: lead

NCT02950883Phase 2Completed

Saline Hypertonic in Preschoolers + CT

Role: lead

NCT02378467Not ApplicableCompleted

Saline Hypertonic in Preschoolers

Role: lead

All 6 trials loaded